|
No. of patients
|
n = 2989
|
n = 506
|
n = 2483
| |
|
Age, years
|
64.5 ± 10.6
|
70.4 ± 8.0
|
63.3 ± 10.7
|
<0.001
|
|
Gender, female, n (%)
|
614 (20.5)
|
162 (32.0)
|
452 (18.2)
|
<0.001
|
|
Body composition parameters
|
|
BMI, kg/m2
|
24.2 ± 2.9
|
24.1 ± 2.8
|
24.2 ± 2.9
|
0.477
|
|
BF, %
|
28.1 ± 6.2
|
30.2 ± 6.6
|
27.7 ± 6.0
|
<0.001
|
|
LMI, kg/m2
|
17.3 ± 1.8
|
16.7 ± 1.9
|
17.4 ± 1.8
|
<0.001
|
|
Medical history
|
|
Current smoking, n (%)
|
902 (30.2)
|
151 (29.8)
|
751 (30.2)
|
0.857
|
|
Pre-hypertension, n (%)
|
1628 (54.5)
|
352 (69.6)
|
1276 (51.4)
|
<0.001
|
|
Pre-diabetes mellitus, n (%)
|
653 (21.8)
|
154 (30.4)
|
499 (20.1)
|
<0.001
|
|
At admission
|
|
Systolic blood pressure, mm Hg
|
130.3 ± 21.2
|
132.0 ± 24.1
|
129.9 ± 20.6
|
0.059
|
|
Diastolic blood pressure, mm Hg
|
76.3 ± 12.5
|
74.2 ± 13.4
|
76.7 ± 12.3
|
<0.001
|
|
Heart rate, beats/min
|
74.1 ± 13.9
|
76.3 ± 16.1
|
73.6 ± 13.4
|
0.001
|
|
Killip classification ≥ II, n (%)
|
344 (11.5)
|
93 (18.4)
|
251 (10.1)
|
<0.001
|
|
Laboratory values
|
|
eGFR, ml/min/1.73 m2
|
79.5 ± 22.9
|
45.9 ± 12.4
|
86.3 ± 18.0
|
<0.001
|
|
Blood glucose, mmol/L
|
6.9 ± 3.1
|
7.7 ± 4.1
|
6.8 ± 2.8
|
<0.001
|
|
Total cholesterol, mmol/L
|
4.1 ± 1.1
|
4.0 ± 1.1
|
4.1 ± 1.1
|
0.222
|
|
Diagnosis
|
|
ACS, n (%)
|
2163 (72.4)
|
382 (75.5)
|
1781 (71.7)
|
0.084
|
|
UA, n (%)
|
1533 (51.3)
|
257 (50.8)
|
1276 (51.4)
|
0.806
|
|
Severity of CAD
|
|
Left main artery, n (%)
|
282 (9.4)
|
54 (10.7)
|
228 (9.2)
|
0.296
|
|
Three vessel diseases, n (%)
|
758 (25.4)
|
176 (34.8)
|
582 (23.4)
|
<0.001
|
|
Discharge medication
|
|
Aspirin, n (%)
|
2760 (92.3)
|
432 (85.4)
|
2328 (93.8)
|
<0.001
|
|
Clopidogrel, n (%)
|
2670 (89.3)
|
428 (84.6)
|
2242 (90.3)
|
<0.001
|
|
Statin, n (%)
|
2678 (89.6)
|
432 (85.4)
|
2246 (90.5)
|
0.001
|
|
ACE inhibitors or ARBs, n (%)
|
1702 (56.9)
|
290 (57.3)
|
1412 (56.9)
|
0.854
|
|
Beta-receptor blockers, n (%)
|
1981 (66.3)
|
301 (59.5)
|
1680 (67.7)
|
<0.001
|
